热门出版物 - 学术资源搜索

h5 指数:48
h5 中位数:69

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#8 Medicinal Chemistry

标题/作者	引用次数	年份
Schiff bases in medicinal chemistry: a patent review (2010-2015) A Hameed, M al-Rashida, M Uroos, S Abid Ali, KM Khan Expert Opinion on Therapeutic Patents 27 (1), 63-79	145	2017
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018) A Nocentini, CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 729-740	124	2018
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016) A Hameed, M Al-Rashida, M Uroos, SA Ali, Arshia, M Ishtiaq, KM Khan Expert Opinion on Therapeutic Patents 28 (4), 281-297	117	2018
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 709-712	116	2018
Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017) X Zuo, Z Huo, D Kang, G Wu, Z Zhou, X Liu, P Zhan Expert Opinion on Therapeutic Patents 28 (4), 299-316	111	2018
A decade of nutraceutical patents: where are we now in 2018? P Daliu, A Santini, E Novellino Expert Opinion on Therapeutic Patents 28 (12), 875-882	107	2018
Solid lipid nanoparticles: a review on recent perspectives and patents R Paliwal, SR Paliwal, R Kenwat, BD Kurmi, MK Sahu Expert Opinion on Therapeutic Patents 30 (3), 179-194	90	2020
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 713-721	89	2018
Sulfonamide inhibitors: a patent review 2013-present İ Gulçin, P Taslimi Expert Opinion on Therapeutic Patents 28 (7), 541-549	89	2018
Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016) H Hussain, IR Green, I Ali, IA Khan, Z Ali, AM Al-Sadi, I Ahmed Expert Opinion on Therapeutic Patents 27 (9), 1061-1072	86	2017
Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018) A Nocentini, CT Supuran, JY Winum Expert Opinion on Therapeutic Patents 28 (6), 493-504	84	2018
Coumarin derivatives: an updated patent review (2015-2016) A Detsi, C Kontogiorgis, D Hadjipavlou-Litina Expert Opinion on Therapeutic Patents 27 (11), 1201-1226	84	2017
Thioredoxin reductase inhibitors: a patent review B Zhang, J Zhang, S Peng, R Liu, X Li, Y Hou, X Han, J Fang Expert Opinion on Therapeutic Patents 27 (5), 547-556	80	2017
P2X7 receptor antagonists: a patent review (2010–2015) JH Park, YC Kim Expert Opinion on Therapeutic Patents 27 (3), 257-267	79	2017
Selective histone deacetylase small molecule inhibitors: recent progress and perspectives HT Qin, HQ Li, F Liu Expert Opinion on Therapeutic Patents 27 (5), 621-636	78	2017
MAO inhibitors and their wider applications: a patent review S Carradori, D Secci, JP Petzer Expert Opinion on Therapeutic Patents 28 (3), 211-226	78	2018
A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018) S Shaabani, HPS Huizinga, R Butera, A Kouchi, K Guzik, ... Expert Opinion on Therapeutic Patents 28 (9), 665-678	76	2018
Marine natural products as source of new drugs: a patent review (2015–2018) P Shinde, P Banerjee, A Mandhare Expert Opinion on Therapeutic Patents 29 (4), 283-309	76	2019
RORγ antagonists and inverse agonists: a patent review SM Bronner, JR Zbieg, JJ Crawford Expert Opinion on Therapeutic Patents 27 (1), 101-112	76	2017
Saffron and its derivatives, crocin, crocetin and safranal: a patent review M Rameshrad, BM Razavi, H Hosseinzadeh Expert Opinion on Therapeutic Patents 28 (2), 147-165	72	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。